Alzheimer's Disease | Progress In Mind

Home

Congress highlights

Effective communication with patients and their families

Communication with patients is a key therapeutic and ethical need in the treatment of psychiatric...

Depression, Alzheimer's Disease

Late-life depression: The needle in a haystack

Identifying depression in the elderly may at times appear to be like looking for a needle in the...

Congress highlights

Brain health becomes a global priority

For years, the massive burden of mortality and morbidity caused by neurological diseases was not...

Alzheimer's Disease, Parkinson's Disease

Congress highlights

A pick of the mix

Though EAN 2020 was virtual, the variety and quality of its presentations was very real. These are...

Alzheimer's Disease

Congress highlights

Latest insights into CADASIL and disorders of consciousness

Anti-Notch3 immunotherapy, subclinical command following, and small fibre neuropathy. All topics...

Alzheimer's Disease

Congress highlights

Early palliative care in progressive neurological diseases

Neurologists are often dealing with chronic diseases that progress in severity. Palliative care...

Alzheimer's Disease

Congress highlights

Study motivated by apathy

Conversion from mild cognitive impairment to Alzheimer’s disease dementia is not related to...

Migraine, Alzheimer's Disease

Congress highlights

Countries need to work together to tackle brain diseases

WHO global initiatives and national treatment pathways are key to reducing the huge burden that...

Alzheimer's Disease

Congress highlights

Guidance needed on biomarker counseling

Clinicians value biomarkers when assessing mild cognitive impairment but are less certain about how...

Alzheimer's Disease

Congress highlights

Imaging advances diagnosis and staging in dementias

Tau-PET imaging in the clinic is on the horizon and would complement amyloid-PET and structural and...

Alzheimer's Disease

Congress highlights

Further evidence of cognitive and health benefits extends lifestyle intervention

The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)...

Alzheimer's Disease

Congress highlights

TDP-43: a newly-recognized route to cognitive decline

There is growing clinical interest in TDP-43 proteinopathy, a relatively recent and fast-moving...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Spain Continue to Progress in Mind Ireland

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind South East Asia
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in South East Asia click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline